Predictors of sorafenib benefit in patients with hepatocellular carcinoma

Richard Jackson, Eftychia Psarelli, Sarah Berhane, Philip J Johnson

Research output: Contribution to journalComment/debatepeer-review

3 Citations (Scopus)
Original languageEnglish
Pages (from-to)619-620
Number of pages2
JournalJournal of Hepatology
Issue number3
Early online date24 Oct 2017
Publication statusPublished - Mar 2018


  • Carcinoma, Hepatocellular
  • Humans
  • Liver Neoplasms
  • Niacinamide
  • Phenylurea Compounds
  • Prognosis
  • Sorafenib

Cite this